Results of Miconazole Therapy in
In a previous report (Negroni et al. 1974 ) we presented the results achieved with oral and intravenous miconazole nitrate in 7 patients with paracoccidioidomycosis. At the same time Santos Lima et al. (1974) reported successful therapeutic results in another 5 patients with this disease, treated orally with miconazole 3 g/day. To these cases we must add the one treated by Stevens (1973) in Belgium, which became the first case to be reported.
The object of this presentation is to report the status of our experience with miconazole in the treatment of paracoccidioidomycosis.
Materials and Methods
Twenty-eight male patients, aged 34 to 66 years (median age: 42) were studied. Their main characteristics are given in Table 1 . The diagnosis of paracoccidioidomycosis was made on the basis of the presence of Paracoccidioides brasiliensis in biopsy samples taken from cutaneous or mucosal lesions in 19 cases, in the sputum of 5 cases or from both sources in the remaining 4 patients. All samples were submitted to mycological and histopathological tests.
Agar gel immunodiffusion and complement fixation tests were also performed, before starting the miconazole treatment and every two months thereafter, using an antigen from P. brasiliensis prepared by the method reported by Negroni (1968) and following the techniques recommended by the Pan American Health Organization (1972, 1974) . The complement fixation test was positive in all patients, with titres ranging from 1/8 to 1/1024. The immunodiffusion test gave positive results in all cases except one.
Skin tests were performed with two specific antigens, using the polysaccharide of the yeastlike phase of P. brasiliensis, according to the method recommended by Fava Netto (1955) , using a supernatant of broken yeast-like cells prepared by the method of Negroni et al. (1975) . These tests were performed simultaneously with the serological reactions. At the start of treatment the skin tests were positive in 18 patients and negative in 10.
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The following complementary examinations were performed every month: hlamatology and sedimentation rate, tests for uremia, glycemia, and liver function, complete urinalysis, chest X-rays and creatinine determinations.
Miconazole was administered according to two different plans: Plan 1 comprised daily intravenous administration of one ampoule of miconazole nitrate (200 mg) diluted in 500 ml of 5 % glucose solution, together with 2.5 g of miconazole (10 tablets) orally. Plan 2 comprised daily intravenous administration of 3 ampoules of miconazole (600 mg) diluted in 500 ml of 5 % glucose solution for 20 days, followed by daily oral administration of 3 g of miconazole (12 tablets).
These therapeutic schemes were followed for 60 days, after which the patients received oral maintenance therapy of 1.5 g daily (6 tablets) for a minimum of two years.
The therapeutic results were classified as follows: very good, when a clinical cure was obtained and the serological tests became negative; good, when a clinical cure was obtained, together with a decrease of the antibodies titre; regular, when only a clinical cure was obtained; poor, when no result was achieved; not assessable, when the medication had to be discontinued due to toxicity, before reaching therapeutic doses.
Fourteen patients had previously received specific therapies: 3 had been treated with sulphonamides; 7 with sulphonamides and amphotericin B; 3 with sulphonamides and sulfa-methoxazole+trimethoprim; one had received these three medications. At the onset of the treatment with miconazole, all the patients had relapsed and the disease was highly active. 
Results
Tables 1-4 show the patients' characteristics, location of lesions, results of miconazole therapy and tolerance to the drug, all in summary form. Table 5 shows the detailed results obtained with miconazole, as reported at the last clinical or laboratory examination of each patient and In 13 patients the serological tests became negative. In 10 there was a decrease of antibody titres. Two patients did not complete the serological controls after the treatment. The serological values did not decrease in one patient and the medication had to be discontinued in two patients due to side-effects.
Skin tests with P. brasiliensis antigens became positive in eight of the 10 patients that were initially negative. The erythrocyte sedimentation rate, which had been higher than 20 mm in the first hour in 22 cases, was reduced after treatment to 10 mm or less in 16 of these cases.
Of the 17 patients who at the onset of therapy showed pulmonary lesions with signs of activity at the X-ray examination, 12 showed complete healing of these lesions during the observation period. 
Conclusions
(1) The therapeutic schemes followed with miconazole, orally and intravenously, led to a clinical cure in 24/28 patients (85 %), with results ranging from good to very good. The medication failed in one patient; another abandoned the treatment in an early stage and two showed signs of intolerance that led to its discontinuation.
(2) These clinical results were confirmed by the laboratory tests normally used to investigate the efficacy of therapy in this disease (Lacaz 1967) . The serological tests became negative in 13/24 cases (54 %). There were marked reductions of antibody titres in 10 patients (41 %). Specific skin tests became positive in 8/10 patients who were initially negative to paracoccidioidin. The sedimentation rate became normal in 16/22 patients (72%).
(3) Miconazole was generally tolerated very well. The following side-effects were observed: venous thrombosis in 8 patients; gastroenteritis in one; anemia in one, palpitations in one; thrombocytopenic purpura with toxidermia and the production of anti-drug antibodies in one. In this last patient we could detec-t antibodies against miconazole by means of an agar gel immunodiffusion test, using miconazole solutions from an ampoule as antigen. Likewise, the intradermal injection of a 1 mg/ml solution of miconazole was followed 10 min later by a wheal reaction and two hours later by a purpuric reaction that persisted until the next day. The histological examination of the cutaneous lesion showed typical signs of toxidermia. (4) We consider it essential to prescribe a maintenance dose after reaching a clinical cure, since 14 patients had been treated previously with drugs of proved efficacy and had relapsed. Because of this we recommend a treatment to enhance the cures obtained, based on a daily oral administration of six tablets (1.5 g) of miconazole. Three patients completed one or more years of treatment, and 7 completed between six months and one year. The results obtained in this group were excellent; no patient relapsed and no signs of toxicity were observed. (5) Miconazole is particularly indicated in patients resistant to sulphonamides or those who have relapsed after being treated with amphotericin B, as shown by the clinical improvement observed in 12 of the 14 patients of this type who were treated (85 %). (6) Although the results obtained so far are very satisfactory, the exact degree of efficacy of miconazole in paracoccidioidomycosis has not been finally established since this disease is typically recurrent, has a chronic evolution and any therapeutic claim has to be made after many years of experience, as done by Sampaio (1963) for sulphonamide therapy.
In this study we have not included an untreated control group of patients, as we knew beforehand that this disease has a fatal evolution when left untreated, as shown by experience stretching from 1908 to 1940. No case of spontaneous remission has so far been reported (Lacaz 1967 , P Negroni 1968 .
Summary
Results are presented of treatment with miconazole, orally and intravenously, in patients with paracoccidioidomycosis. Twenty-eight male patients aged from 34 to 66 years and exhibiting various clinical forms of the disease were studied. Twenty-five came from endemic areas in north east Argentina (Chaco, Formosa, Misiones, Corrientes and northern Santa Fe) and the remaining three from Paraguay. Twenty patients were engaged in agricultural work or at wood mills. Single or multiple lesions were observed in 24 cases. Thirteen were suffering from infection of the larynx and in two of them a tracheotomy was necessary. Twenty-three showed pulmonary lesions on X-rays. Twelve had ganglionic lesions, eight had cutaneous lesions and one patient had osteoarthritis of the knee. One patient had hepatomegaly which was unrelated to chronic alcoholism.
Fourteen patients had received previous treatments such as sulphonamides and amphotericin B (7 cases); sulphonamides (3), sulphonamides and the combination sulfamethoxazole+trimethoprim (3), and one patient had received all three medications. All patients had relapsed before starting miconazole therapy.
Diagnosis was established by the presence of P. brasiliensis in all cases, recovered either frormi cutaneous or mucosal biopsy samples or from the sputum. Complement fixation tests were positive in all patients at the onset of the treatment and the immunodiffusion reactions showed precipitation bands in 27/28 patients. Skin tests with P. brasiliensis antigens proved to be positive in 18 cases and negative in 10. The erythrocyte sedimentation rate was markedly accelerated in 22 patients (>20 mm in the first hour).
Two therapeutic schemes were used. The first consisted of the daily administration of 2.5 g of miconazole by mouth and one ampoule (200 mg) intravenously, diluted in 500 ml of a 5 % glucose solution. The second involved the daily administration of 3 ampoules of miconazole (600 mg) intravenously, diluted in 500 ml of a 5% glucose solution for 20 days, followed by a daily oral administration of 12 tablets (3 g). Both plans were continued for 60 days, after which maintenance therapy was prescribed, consisting of a daily oral administration of 6 tablets (1.5 g). The duration of treatment and clinical control ranged from 12 days to 2 years, being six months or more in 10 10 patients.
The results obtained were classified as very good in 13 cases; good in 11, regular in one, poor in one and not assessable in two.
Miconazole was generally tolerated very well. The following side-effects were observed: venous thrombosis in 8 patients, gastroenteritis in one, anemia in one, palpitations in one, and thrombocytopenic purpura, toxidermia and the production of anti-drug antibodies in one other patient.
Laboratory tests showed that serological reactions became negative in 54% of the cases. There was a marked reduction of titres in 41 %. The erythrocyte sedimentation rate was normalized in 72 % and skin tests became positive in 80 % of the 10 patients who were previously negative to paracoccidioidin.
Nodular and exudative pulmonary lesions which were revealed by X-ray examination in 17 patients, disappeared in the course of the observation period in 12 (70%).
